» Articles » PMID: 17212477

Recent Progress in Development of Dopamine Receptor Subtype-selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders

Overview
Journal Chem Rev
Specialty Chemistry
Date 2007 Jan 11
PMID 17212477
Citations 58
Authors
Affiliations
Soon will be listed here.
Citing Articles

Dual-recognition driven sensing platform based on a BSA-Cu NP nanozyme combined with smartphone-assistance for fluorometric/colorimetric monitoring of dopamine.

Feng D, Wang S, Yu Z, Zhang W, Liu G RSC Adv. 2025; 15(1):199-206.

PMID: 39758891 PMC: 11694503. DOI: 10.1039/d4ra07209j.


CMOS Point-of-Care Diagnostics Technologies: Recent Advances and Future Prospects.

Moeinfard T, Ghafar-Zadeh E, Magierowski S Micromachines (Basel). 2024; 15(11).

PMID: 39597132 PMC: 11596111. DOI: 10.3390/mi15111320.


Development and Biomedical Application of Non-Noble Metal Nanomaterials in SERS.

Chen L, Liu H, Gao J, Wang J, Jin Z, Lv M Nanomaterials (Basel). 2024; 14(20).

PMID: 39452990 PMC: 11510763. DOI: 10.3390/nano14201654.


β-Phenethylamine Synthesis: N-Pyridinium Aziridines as Latent Dual Electrophiles.

Samanta S, Biswas P, OBannon B, Powers D Angew Chem Int Ed Engl. 2024; 63(31):e202406335.

PMID: 38699820 PMC: 11262962. DOI: 10.1002/anie.202406335.


Chiral arylsulfinylamides as reagents for visible light-mediated asymmetric alkene aminoarylations.

Hervieu C, Kirillova M, Hu Y, Cuesta-Galisteo S, Merino E, Nevado C Nat Chem. 2024; 16(4):607-614.

PMID: 38228849 PMC: 10997517. DOI: 10.1038/s41557-023-01414-8.